Marc Hedrick
Fortune : 163 420 $ au 31/05/2026
Fortune : 163 420 $ au 31/05/2026
Marc H.
Hedrick was the founder of StemSource, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2001 to 2003.
Dr. Hedrick currently holds the positions of President, Chief Executive Officer & Director at Plus Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Cytori Therapeutics, Inc. (JP); Chief Scientific Officer & Medical Director at MacroPore Biosurgery, Inc. from 2002 to 2004; Co-Director at UCLA Anderson School of Management; Director at Cytori Ltd.; and Associate Professor at the University of California, Los Angeles.
Education includes a doctorate from The University of Texas Southwestern Medical Center conferred in 1988 and an MBA from UCLA Anderson School of Management conferred in 2005.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 28 044 ( 0,41% ) | 163 216 $ | 31/05/2026 | |
| 25/07/2018 | 35 ( -.--% ) | 204 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Directeur Général | 02/04/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Directeur Technique/Scientifique/R&D | 01/01/2004 |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Fondateur | 01/01/2003 |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
MacroPore Biosurgery, Inc. /Old/
MacroPore Biosurgery, Inc. /Old/ Medical SpecialtiesHealth Technology Manufactures biocompatible surgical implants for the reconstruction and regeneration of bones | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatements to cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytori Ltd.
Cytori Ltd. Pharmaceuticals: OtherHealth Technology Develops biological products | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Provides cell therapy treatments and services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national